This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2007;121(1):51-3.

doi: 10.1016/j.thromres.2007.03.015. Epub 2007 Apr 25.

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins

Sergio Siragusa¹, Alessandra Malato, Valeria Cigna, Raffaela Anastasio, Lucio Lo Coco, Alessandra Casuccio, Marcello Ciaccio

Affiliations

PMID: 17462714
DOI: 10.1016/j.thromres.2007.03.015

Clinical Trial

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins

Sergio Siragusa et al. Thromb Res. 2007.

. 2007;121(1):51-3.

doi: 10.1016/j.thromres.2007.03.015. Epub 2007 Apr 25.

Authors

Sergio Siragusa¹, Alessandra Malato, Valeria Cigna, Raffaela Anastasio, Lucio Lo Coco, Alessandra Casuccio, Marcello Ciaccio

Affiliation

¹ Thrombosis/Haemostasis and Haematology Unit, University Hospital of Palermo, Italy. sergio.siragusa@unipa.it

PMID: 17462714
DOI: 10.1016/j.thromres.2007.03.015

No abstract available

PubMed Disclaimer

Similar articles

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. Stanger O, et al. Z Kardiol. 2004 Jun;93(6):439-53. doi: 10.1007/s00392-004-0075-3. Z Kardiol. 2004. PMID: 15252738 Review.
Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T. Alvares Delfino VD, et al. Nutrition. 2007 Mar;23(3):242-7. doi: 10.1016/j.nut.2007.01.002. Epub 2007 Feb 22. Nutrition. 2007. PMID: 17321110 Clinical Trial.
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH. Azadibakhsh N, et al. Saudi J Kidney Dis Transpl. 2009 Sep;20(5):779-88. Saudi J Kidney Dis Transpl. 2009. PMID: 19736473 Clinical Trial.
[Group B vitamins as new variables related to the cardiovascular risk].
Granieri M, Bellisarii FI, De Caterina R. Granieri M, et al. Ital Heart J Suppl. 2005 Jan;6(1):1-16. Ital Heart J Suppl. 2005. PMID: 15776726 Review. Italian.
[Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H, Young P, Díaz ML, Schropp J, Forrester M, Freixas E. Trimarchi H, et al. Medicina (B Aires). 2005;65(6):513-7. Medicina (B Aires). 2005. PMID: 16433478 Spanish.

See all similar articles

Cited by

Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease.
Bellia C, Bivona G, Scazzone C, Ciaccio M. Bellia C, et al. Ther Clin Risk Manag. 2007 Dec;3(6):999-1001. Ther Clin Risk Manag. 2007. PMID: 18516267 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information